AfroCentric Investment Corporation, a Johannesburg Stock Exchange-listed healthcare firm, has announced the sale of its pharmaceutical unit, Activo Health, to Portuguese pharmaceutical giant FHC Group. This sale marks a pivotal shift in AfroCentric’s operational focus. The group is moving away from pharmaceutical manufacturing and marketing. AfroCentric Divests Activo Health In Portfolio Overhaul AfroCentric’s subsidiary, ACT Healthcare Assets, entered into an…